Zhejiang DIAN Diagnostics Co., Ltd. (referred to as “Dian Diagnostics” or “Dian”) was founded in 2001 to be an independent third-party medical diagnostic service institution with the diagnostic service outsourcing as its core business; with DIAN’s characteristic “services + products” integrated business model, it has become an industry leader, and in July 2011, it was the first to be listed (stock code: 300244).
As DIAN’s main business, the independent medical laboratory’s brand new operation model covers such new modern service types as professional cold chain logistics, high-tech diagnostic techniques and information technology, etc., all belonging to modern technology services. By centralized tests, intensive operation and chain development, it can improve public health resources utilization, optimize medical test resources, reduce medical costs and promote test technology development.
Currently, relying on the platform of national medical laboratories chain, DIAN is committed to technology and business model innovations with businesses in such areas as forensic authentication, diagnostic products sales, diagnostics R&D and CRO, etc. and continuous improvement of the “services + products” integrated professional service system to create a third-party medical diagnostic service mode with complete diagnosis items, efficient specimen process, accurate diagnostic results and authoritative consulting service, forming the integrated marketing competitive advantage, determining the expansion strategy of national chain and scale replication, accelerating the nationwide deployment through effective integration of both vertical and horizontal resources, and launching the development strategy of multi-service areas expansion and upstream and downstream industry chain integration of public test platform.
DIAN has an expert team consisting of masters, doctors and both domestic and overseas medical diagnostics top scholars, has strategic cooperation with such world class enterprises and institutions as Roche Diagnostics, French bioMerieux, NMS, and US Bill/Melinda Gates Foundation, etc. and such domestic well-known enterprises, colleges and research institutes as Fosun Pharmaceutical, Wenzhou Medical College, and Zhejiang Tsinghua Yangtze River Delta Academy Biotech and Pharmaceutical Institute, and wins the support of a number of research fund projects such as NDRC service industry development guidance fund and “National Key Technology Support Program”, etc. Its HangzhouDianMedicalDiagnosticCenterand Nanjing Medical Diagnostic Laboratory are national high-tech enterprises.